AKT1 and lung carcinoma: To confirm the effect of CIN-RM suppressing CSCs through the Akt/c-Myc signaling pathway on other lung cancer cells, H23 and H292 cells were treated with various concentrations of CIN-RM (0, 10, and 20 μM) and investigated for key regulatory proteins by Western blot analysis.